Global X China Tech ETF (ASX:DRGN): Focused Exposure to 21 of China’s Technology Leaders

Sonal Goyal

20 October 2026 05:41 PM AEDT

Global X China Tech ETF (ASX:DRGN): Focused Exposure to 21 of China’s Technology Leaders

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key highlights

ASX:DRGN tracks the Global X China Tech 20 Index and is fully invested in China (100%).
The portfolio holds 21 companies, with the top ten accounting for 77.39% of the fund.
The fund has about $75.17 million in assets and a 0.45% management fee.

The Global X China Tech ETF (ASX:DRGN) provides exposure to a concentrated group of Chinese technology companies in a single ASX trade. The fund aims to provide a return that, before fees and expenses, tracks the performance of the Global X China Tech 20 Index.

About the Fund

DRGN was admitted to the ASX on 8 May 2025 and is classified in the Equity Greater China category. Its benchmark is the Global X China Tech 20 Total Return Index in Australian dollars. The fund has about $75.17 million in assets, and the management fee is 0.45%.

An announcement on 15 October 2026 noted the appointment of Citigroup Pty Limited as fund service provider.

Country exposure

The fund’s entire country allocation is to China (100%).

All holdings are companies with a market value above $1 billion, and stocks represent 99.92% of the portfolio.

Portfolio holdings

The portfolio holds 21 companies, with top ten holdings making up 77.39% of the fund. The largest positions are Eoptolink Technology Inc Ltd Class A (8.62%), Tencent Holdings Ltd (8.34%), Zhongji Innolight Co Ltd Class A (8.33%), East Money Information Co Ltd Class A (8.1%) and Xiaomi Corp Class B (7.99%).

The remaining top ten holdings are Shengyi Technology, GigaDevice Semiconductor, Advanced Micro-Fabrication Equipment, Suzhou Dongshan Precision Manufacturing and Hithink RoyalFlush Information Network. Several of the holdings are mainland China A-share listings.

Understanding the exposure

The five largest positions add up to 41.38% of the fund, which shows how much of the exposure rests on a small number of names. The remaining 11 holdings share the other 22.61% of the portfolio, an average of about 2.06% each. Every holding is based in China, so the fund’s exposure sits entirely in that one market and it has no allocation to other countries.

Fees, size and distributions

The most recent distribution was a final distribution of $0.711 per unit, with an ex-date of 2 July 2026 and payment on 16 July 2026, and the reported annual yield is 7.58%.

Fund structure and reporting

DRGN has an ISIN of AU0000390049 and a head office at Level 16, 20 Martin Place, Sydney. Recent ASX announcements from the fund include the appointment of Citigroup Pty Limited as fund service provider, a units-on-issue notice for September 2026 and the annual financial report lodged on 25 September 2026.

Equity Greater China funds invest in the securities of companies listed in China, including Hong Kong and Taiwan, with securities from these markets typically accounting for at least 75% of the portfolio.

Units in DRGN are quoted on the ASX and can be bought and sold through a broker during trading hours, in the same way as shares, so the exposure described above is available without buying each holding separately. The fund follows a rules-based index, so its holdings and weightings are set by the index methodology and adjusted when the index is rebalanced.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.